QuantRx Biomedical Report issue

For profit Phase 2
Founded: Tualatin OR United States (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

Key: QuantRx Biomedical (0) Acquired (2)

agn-195183 (1 trial)

nrx194204 (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 2
  • # of Trial APIs: 2